Jonathan Allan, GENERAL COUNSEL & Corporate Secretary at Stoke Therapeutics, Inc. (STOK), sold 6,656 shares at $32.61 ($216K) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($216k) by GENERAL COUNSEL & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.60 | 1,300 | $41K | 19.0% |
| 2 | $32.61 | 2,678 | $87K | 40.5% |
| 3 | $32.61 | 2,678 | $87K | 40.5% |
| Total | $32.41 avg | 6,656 | $216K | 100% |
| Filing → |
| STOK | SELL | 2026-06-18 | $44K | — | Filing → |
| STOK | SELL | 2026-03-24 | $626K | — | Filing → |
| STOK | SELL | 2026-03-19 | $569K | — | Filing → |